Healthcare Capital Corp Announces Special Meeting Date for
Special Meeting Scheduled for February 15, 2022 The combined company will be named Alpha Tau Medical Ltd. and remain listed on the...
Stay updated with breaking news from Alpha Da. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Special Meeting Scheduled for February 15, 2022 The combined company will be named Alpha Tau Medical Ltd. and remain listed on the...
The company said that all 10 patients reached the secondary endpoint for measurement of tumor response to its alpha-radiation cancer therapy.
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has been notified by HekaBio K.K., its clinical trial partner in Japan, that recruitment has been completed in its open-label multi-center pivotal study evaluating the Alpha DaRT in Japanese patients with recurrent Head & Neck cancer after radiotherapy. - Click here if this is your press release! - eTurboNews | Trends | Travel News
/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has...
/PRNewswire/ -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that it has...